As of Jun 22, 2026, the Electromed stock's PE ratio is 31.48. This results from the current EPS of $1.22 and stock price of $38.4. The P/E ratio has an increase of 31% from the past four quarters average of 24.1.
The PE ratio of Electromed has averaged 28.34 over the last ten years. The current PE ratio of 31.48 is 11% above the historical average. Over the past ten years, ELMD's PE ratio was at its highest in the Dec 2021 quarter at 56.52, when the stock price was $13 and the EPS was $0.23. The lowest value was in the Jun 2016 quarter, when it reached 14.3 with a price of $3.86 and an EPS of $0.27.
Maximum annual increase: 345.48% in 2012
Maximum annual decrease: -18.91% in 2023
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2025 | 24.71 | -1.36% | $21.99 | $0.89 |
| 2024 | 25.05 | -13.47% | $15.03 | $0.6 |
| 2023 | 28.95 | -18.91% | $10.71 | $0.37 |
| 2022 | 35.7 | -11.46% | $9.64 | $0.27 |
| 2021 | 40.32 | 30.99% | $11.29 | $0.28 |
| 2020 | 30.78 | 35.54% | $15.39 | $0.5 |
| 2019 | 22.71 | -7.83% | $5.45 | $0.24 |
| 2018 | 24.64 | 20.31% | $5.42 | $0.22 |
| 2017 | 20.48 | 43.22% | $5.53 | $0.27 |
| 2016 | 14.3 | 0.49% | $3.86 | $0.27 |
| 2015 | 14.23 | N/A | $1.85 | $0.13 |
| 2014 | N/A | N/A | $1.42 | -$0.16 |
| 2013 | N/A | N/A | $1.27 | -$0.16 |
| 2012 | 105 | 345.48% | $2.1 | $0.02 |
| 2011 | 23.57 | N/A | $3.3 | $0.14 |
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Mar 2026 | 19.19 | -29.47% | $23.41 | $1.22 |
| Dec 2025 | 27.21 | 7.51% | $29.12 | $1.07 |
| Sep 2025 | 25.31 | 2.43% | $24.55 | $0.97 |
| Jun 2025 | 24.71 | -14.05% | $21.99 | $0.89 |
| Mar 2025 | 28.75 | -24.1% | $23.86 | $0.83 |
| Dec 2024 | 37.88 | 32.31% | $29.55 | $0.78 |
| Sep 2024 | 28.63 | 14.29% | $21.47 | $0.75 |
| Jun 2024 | 25.05 | -20.9% | $15.03 | $0.6 |
| Mar 2024 | 31.67 | 36.45% | $16.15 | $0.51 |
| Dec 2023 | 23.21 | -12.88% | $10.91 | $0.47 |
| Sep 2023 | 26.64 | -7.98% | $10.39 | $0.39 |
| Jun 2023 | 28.95 | -16.5% | $10.71 | $0.37 |
| Mar 2023 | 34.67 | -17.37% | $10.4 | $0.3 |
| Dec 2022 | 41.96 | -5.86% | $10.49 | $0.25 |
| Sep 2022 | 44.57 | 24.85% | $10.25 | $0.23 |
The Historical Valuation Regime chart shows where the stock's current valuation sits relative to its own historical valuation range over the selected lookback period.
This is a history-relative tool, not a market-relative percentile. It does not compare the stock to other companies. Instead, it compares each historical valuation reading to the stock's own past readings.
The threshold lines are calculated them from the stock's real historical values using percentile interpolation. That is why some colored bands are narrow while others are wide: the band widths reflect how the stock actually traded through time.
| Historical percentile | Regime | Chart meaning |
|---|---|---|
| 0-10 | Historically Low | Deep cheap zone |
| >10-25 | Below Average | Cheap relative to history |
| >25-75 | Average | Within the normal historical range |
| >75-90 | Above Average | Expensive relative to history |
| >90-100 | Historically High | Extreme or stretched valuation |
| Chart element | What it tells you |
|---|---|
| Main line | The actual historical valuation values over time for the selected metric. |
| Dashed horizontal lines | The stock's computed P10, P25, Median, P75, and P90 thresholds for the selected period. |
| Colored bands | The historical valuation zones between those thresholds. |
| Metric boxes | Current ratio, historical median, current percentile, and current regime. |
| Timeline strip | A condensed regime history showing how the stock moved between cheap, fair, and expensive states across each observation. |
Current Percentile is the percentile rank of the latest valid historical observation within the selected lookback range.
Current Regime is assigned directly from the latest observation's percentile bucket using the fixed 10 / 25 / 75 / 90 cutoffs shown above.
This chart is most useful for answering a narrow question: Is this stock trading high, low, or normal relative to its own history? It works best alongside growth, profitability, and forward-looking business analysis, because a stock can deserve a higher or lower regime if its business quality has changed.
Currently, ELMD's PE ratio is above the 3 and 10-year historical averages, but it is below the 5-year average.
With a P/E of 31.48, ELMD is above the Healthcare sector and the industry average. Compared to its Healthcare sector average of 24.1, Electromed's P/E is 31% higher.
ELMD's PE ratio is higher than its peer stocks RMD and MMSI.
| Stock name | PE ratio | Market cap |
|---|---|---|
| RMD Resmed Inc | 18.4 | $27.76B |
| MMSI Merit Medical Systems Inc | 28.61 | $4.01B |
| ELMD Electromed Inc | 31.65 | $319.69M |
| INGN Inogen Inc | N/A | $177.34M |
The price to earnings ratio for ELMD stock as of Jun 22, 2026, stands at 31.48.
The average PE ratio for ELMD stock over the past 3 years is 27.27.
The average PE ratio for ELMD stock over the past 5 years is 33.27.
The highest quarterly PE ratio in the last ten years has been 56.52 and it was in the Dec 2021 quarter.
ELMD's price to earnings ratio is currently 11% above its 10-year historical average.
To determine the PE ratio, divide the most recent stock price by the TTM earnings per share (EPS). As of today (Jun 22, 2026), Electromed's stock price is $38.4. The earnings per share for the trailing twelve months (TTM) ending Mar 2026 is $1.22. Therefore, Electromed's P/E ratio for today is 31.48. PE RATIO(31.48) = STOCK PRICE($38.4) / TTM EPS($1.22)
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.